| Literature DB >> 29566971 |
Xavier Muñoz1, María José Álvarez-Puebla2, Ebymar Arismendi3, Lourdes Arochena4, María Del Pilar Ausín5, Pilar Barranco6, Irina Bobolea3, Jose Antonio Cañas4, Blanca Cardaba4, Astrid Crespo7, Victora Del Pozo4, Javier Domínguez-Ortega6, María Del Mar Fernandez-Nieto4, Jordi Giner7, Francisco Javier González-Barcala8, Juan Alberto Luna6, Joaquim Mullol3, Iñigo Ojanguren9, José María Olaguibel2, César Picado3, Vicente Plaza7, Santiago Quirce6, David Ramos7, Manuel Rial4, Christian Romero-Mesones9, Francisco Javier Salgado8, María Esther San-José8, Silvia Sánchez-Diez9, Beatriz Sastre4, Joaquin Sastre4, Lorena Soto7, Montserrat Torrejón7, Marisa Urnadoz2, Luis Valdes8, Antonio Valero3, María Jesús Cruz9.
Abstract
The general aim of this study is to create a cohort of asthma patients with varying grades of severity in order to gain greater insight into the mechanisms underlying the genesis and course of this disease. The specific objectives focus on various studies, including imaging, lung function, inflammation, and bronchial hyperresponsiveness, to determine the relevant events that characterize the asthma population, the long-term parameters that can determine changes in the severity of patients, and the treatments that influence disease progression. The study will also seek to identify the causes of exacerbations and how this affects the course of the disease. Patients will be contacted via the outpatient clinics of the 8 participating institutions under the auspices of the Spanish Respiratory Diseases Networking System (CIBER). In the inclusion visit, a standardized clinical history will be obtained, a clinical examination, including blood pressure, body mass index, complete respiratory function tests, and FENO will be performed, and the Asthma Control Test (ACT), Morisky-Green test, Asthma Quality of Life Questionnaire (Mini AQLQ), the Sino-Nasal Outcome Test 22 (SNOT-22), and the Hospital Anxiety and Depression scale (HADS) will be administered. A specific electronic database has been designed for data collection. Exhaled breath condensate, urine and blood samples will also be collected. Non-specific bronchial hyperresponsiveness testing with methacholine will be performed and an induced sputum sample will be collected at the beginning of the study and every 24 months. A skin prick test for airborne allergens and a chest CT will be performed at the beginning of the study and repeated every 5 years.Entities:
Keywords: Asma eosinofílica; Asma neutrofílica; Biomarcadores; Biomarkers; Bronchiectasis; Bronquiectasias; Eosinophilic asthma; Epigenetics; Epigenética; Exacerbaciones; Exacerbations; Fenotipo; Fixed airflow obstruction; Neutrophilic asthma; Obstrucción fija; Phenotype
Year: 2018 PMID: 29566971 DOI: 10.1016/j.arbres.2017.12.012
Source DB: PubMed Journal: Arch Bronconeumol (Engl Ed) ISSN: 0300-2896 Impact factor: 4.872